Skip to main content

Russell Alan J's Form 4 filing

Edgewise Therapeutics, Inc. (EWTX) · filed Sep 24, 2024

Accession no.
0001562180-24-006947
Filed
Sep 24, 2024, 8:25 PM ET
Trade date
Sep 20, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.12M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Russell Alan JCIK 0001853529Director, Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 20, 2024Common StockMOption exerciseAcquired+75,000$0.18+$13,50087,719Direct
Sep 20, 2024Common StockSSaleDisposed−74,185$28.25−$2,096,052.6613,534Direct
Sep 20, 2024Common StockSSaleDisposed−815$29.51−$24,048.5312,719Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 20, 2024Common StockMOption exerciseDisposed−75,000$0.00$01,456,780Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)